Article
Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis.
Journal of chemotherapy (Florence, Italy) - 1 Nov 2023
Wang Zheming, Tang Zhihua, Heidari Hamid, Molaeipour Leila, Ghanavati Roya, Kazemian Hossein, Koohsar Faramarz, Kouhsari Ebrahim
Abstract excerpt
Pyrazinamide (PZA) is an essential first-line tuberculosis drug for its unique mechanism of action active against multidrug-resistant-TB (MDR-TB). Thus, the aim of updated meta-analysis was to estimate the PZA weighted pooled resistance (WPR) rate in M. tuberculosis isolates based on publication date and WHO regions. We systematically searched the related reports in PubMed, Scopus, and Embase (from January 2015...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
